7AGE
Protease Sapp1p from Candida parapsilosis in complex with KB32
7AGE の概要
エントリーDOI | 10.2210/pdb7age/pdb |
関連するPDBエントリー | 3TNE |
分子名称 | Candidapepsin, Pepstatin, DI(HYDROXYETHYL)ETHER, ... (4 entities in total) |
機能のキーワード | secreted aspartic protease, virulence factor, candidiasis, peptidomimetic inhibitors, antibiotic |
由来する生物種 | Candida parapsilosis (Yeast) 詳細 |
タンパク質・核酸の鎖数 | 8 |
化学式量合計 | 148098.09 |
構造登録者 | |
主引用文献 | Dostal, J.,Brynda, J.,Vankova, L.,Zia, S.R.,Pichova, I.,Heidingsfeld, O.,Lepsik, M. Structural determinants for subnanomolar inhibition of the secreted aspartic protease Sapp1p from Candida parapsilosis . J Enzyme Inhib Med Chem, 36:914-921, 2021 Cited by PubMed Abstract: Pathogenic yeasts frequently cause infections in hospitals. Antifungal drugs lose effectiveness due to other species and resistance. New medications are thus required. Secreted aspartic protease of (Sapp1p) is a promising target. We have thus solved the crystal structures of Sapp1p complexed to four peptidomimetic inhibitors. Three potent inhibitors (K: 0.1, 0.4, 6.6 nM) resembled pepstatin A (K: 0.3 nM), a general aspartic protease inhibitor, in terms of their interactions with Sapp1p. However, the weaker inhibitor (K: 14.6 nM) formed fewer nonpolar contacts with Sapp1p, similarly to the smaller HIV protease inhibitor ritonavir (K: 1.9 µM), which, moreover, formed fewer H-bonds. The analyses have revealed the structural determinants of the subnanomolar inhibition of aspartic protease. Because of the high similarity between Saps from different species, these results can further be used for the design of potent and specific Sap inhibitor-based antimycotic drugs. PubMed: 33843395DOI: 10.1080/14756366.2021.1906664 主引用文献が同じPDBエントリー |
実験手法 | X-RAY DIFFRACTION (1.3 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード
